US FDA Publishes, Then Withdraws, PDUFA Rates Because Process ‘May Not Be Well Understood’

User fees for FY 2021 were set to increase nearly 11%, but could have gone even higher; a new notice will be issued but timing is unclear.

Cash drawer with currency
FDA officials announced the new prescription drug user fees, but then withdrew the notice. • Source: Alamy

US Food and Drug Administration officials decided to pull the announcement of fiscal year 2022 prescription drug user fees apparently due to a misunderstanding of the calculations.

The unusual move came as the agency had decided to raise application fees nearly 11% and the program fee more...

More from User Fees

More from Pathways & Standards